Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC Pink: INNPF) (the "Company" or "Innocan"), is pleased to announce the successful completion of a large-scale production of exosomes.

SARASOTA, FL, June 07, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel ...

German pharmaceutical company BioNTech ... but also data on production quality,” Sahin added. In July, the US Department of Health and Human Services and Department of Defense announced a ...

SCHOTT Pharma opens state-of-the-art production facility in Lukácsháza, Hungary 14.06.2024 / 12:58 CET/CEST The issuer is solely responsible for the content of this announcement. Expanding ...